Temple acquires London longevity practice Longevous ahead of wearable launch
Deepinder Goyal-founded health-tech venture Temple has acquired Longevous for an undisclosed sum, adding clinical expertise as it prepares limited pre-orders and a commercial rollout of its health-monitoring wearable by end-2026.
What happened
Deepinder Goyal-founded health-tech venture Temple acquired London longevity practice Longevous to strengthen clinical leadership ahead of pre-orders and a
Key facts
- 1-250 Entropy metric scale
- about two months of testing
- shipments planned before end-2026
Why this matters
Temple’s move shows how acquiring a specialist practice can accelerate clinical capability-building ahead of a regulated consumer-health product launch.
What to watch
- Details on wearable sensors, health metrics, price and pre-order terms.
- Whether Temple launches a recurring membership that includes consultations, tests or personalized protocols.
- Clinical validation studies, regulatory filings, medical-device certifications or changes in product claims.
- Longevous physician retention, expansion of clinic capacity and integration of its brand into Temple.
- Partnerships with labs, insurers, employers, hospitals or wearable-component suppliers.
- Evidence that Temple is targeting India, the UK or other markets first, which will determine regulatory and operating complexity.
- Pre-order conversion, waitlist size and the split between device-only and clinician-supported demand.
- Integrate Longevous clinicians and protocols into Temple's product, app and customer-onboarding design.
- Define whether the wearable will be sold as a wellness device, a clinical-monitoring tool, or a tiered combination of both.
- Build consent, health-data governance and clinical escalation workflows before collecting large-scale user data.
- Use limited pre-orders to test pricing, subscription attachment and demand for clinician-supported plans.
- Pursue partnerships with diagnostics labs, hospitals, employers, insurers or premium wellness networks to lower customer-acquisition costs.
- Recruit additional medical, regulatory, hardware-validation and data-security talent ahead of the end-2026 launch.